Replies to post #163574 on Cytodyn Inc (CYDY)

[Latane]

DiscusDude,

It was explained by NP in his last Proactive video that we do not have enough S/C patients now in the US to quickly enroll CD16/17. Thus the Brazil trial is very good news as CytoDyn will be able to enroll there very quickly (hopefully at 4 dosings!). News from the PI if good will only further boost interest in our results in Brazil and the Brazilians will likely give us an EUA while our FDA and Fauci continue to slow roll us forever.